SCHEMBL13430277

SCHEMBL13430277

CN(C)CCCOc1ccc2c(NCCC3CN=C(NC(=O)Nc4ccccc4)S3)ccnc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AURKA O14965 9/20 0.52
▸ AURKB Q96GD4 5/20 0.43
▸ CSF1R P07333 2/20 0.43
▸ NTRK1 P04629 1/20 0.43
▸ FLT3 P36888 1/20 0.43
▸ NTRK3 Q16288 1/20 0.43
▸ NTRK2 Q16620 1/20 0.43
▸ FERMT2 Q96AC1 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39
▸ HTR1A P08908 2/20 0.38
▸ ADRA1D P25100 2/20 0.38
▸ ADRA1A P35348 2/20 0.38
▸ ADRA1B P35368 2/20 0.38
▸ GSK3A P49840 1/20 0.38
▸ GSK3B P49841 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ FAAH O00519 1/20 0.37
▸ PDGFRA P16234 1/20 0.37
▸ HTR2C P28335 1/20 0.36
▸ HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13430228 0.88 AURKA (0.69) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430279 0.85 AURKA (0.39) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430291 0.84 AURKA (0.49) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430286 0.82 AURKA (0.41) AURKAAURKBHRH3KDRFAAH
SCHEMBL13399878 0.82 AURKA (0.76) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430288 0.81 AURKA (0.39) AURKAAURKBHRH3
SCHEMBL13430294 0.79 AURKA (0.55) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13399881 0.79 AURKA (0.78) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430283 0.79 AURKA (0.54) AURKAAURKBCSF1RNTRK1FLT3
SCHEMBL13430229 0.77 AURKA (0.56) AURKAAURKBKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765953-B2 Compounds and methods for the treatment of pain and other diseases AQUILUS PHARMACEUTICALS, INC. (US) 2014-07-01 — — US disclosed
WO-2010036629-A2 FUSED MULTICYCLIC COMPOUNDS AS PROTEIN KINASE INHIBITORS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2010-04-01 — — WO disclosed
Send feedback